Drug Research
Syneos Health Extends Partnership with Medable
Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced it has extended its strategic partnership with Medable, the industry-leading technology platform for patient-centered clinical...
Drug Research
Hovione and GEA announce a strategic collaboration to advance Continuous Tableting
Hovione and GEA announced a strategic collaboration to advance Continuous Tableting. This partnership stemmed from a successful customer-supplier relationship spanning several years. It combines GEA´s...
News
Hyperparathyroidism: Symptoms, Causes and Treatment
Hyperparathyroidism is an extremely prevalent endocrine disorder. Recent studies reveal that about 80% of people in Western countries suffer from parathyroids. Additionally, about 1,00,000 people...
Clinical Trials
Canadian And US Pharma Firms To Test Psychedelic Drugs In UK
To take advantage of the UK's quick medication approval procedures, the North American psychedelic drug companies Mindset, PharmAla, Mydecine, and Psyence have inked a contract...
News
Swiss and French Health Authorities Expand Recommendations for Use of Nuvaxovid COVID-19 Vaccine as a Booster
Novavax announced that Switzerland’s Federal Office of Public Health (FOPH) and France’s Haute Autorité de Santé (HAS) have expanded their recommendations for use of Nuvaxovid™(NVX-CoV2373)...
News
Evaxion and ExpreS2ion initiate research collaboration on a novel cytomegalovirus (CMV) vaccine candidate
Evaxion Biotech A/S , a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, announces that the Company has signed a Vaccine Discovery Collaboration...
Clinical Trials
Immix Biopharma Announces Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial
Immix Biopharma, Inc, a biopharmaceutical company pioneering Tissue-Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases, announced patient dosing in its ongoing Phase 1b/2a IMX-110 monotherapy...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.